Jeffrey Stuart Peters's most recent trade in Macrogenics Inc was a trade of 150,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 25,000 | 25,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 13,332 | 0 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 13,332 | 36,252 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. | 12 Feb 2026 | 5,147 | 31,105 (0%) | 0% | 1.7 | 8,801 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 8,999 | 26,394 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 8,999 | 9,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 6,001 | 19,712 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 6,001 | 11,999 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 07 Feb 2026 | 3,474 | 22,920 (0%) | 0% | 1.8 | 6,288 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 07 Feb 2026 | 2,317 | 17,395 (0%) | 0% | 1.8 | 4,194 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 13,332 | 13,332 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 13,332 | 18,858 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share. | 15 Feb 2025 | 5,147 | 13,711 (0%) | 0% | 2.6 | 13,176 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 18,000 | 18,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 9,001 | 9,001 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 9,001 | 17,999 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 07 Feb 2025 | 3,475 | 5,526 (0%) | 0% | 2.6 | 9,035 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.82 per share. | 04 Apr 2024 | 42,500 | 51,395 (0%) | 0% | 4.8 | 204,850 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 42,500 | 127,500 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 04 Apr 2024 | 42,500 | 8,895 (0%) | 0% | 15.1 | 640,475 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Sale of securities on an exchange or to another person at price $ 17.74 per share. | 04 Apr 2024 | 5,351 | 3,165 (0%) | 0% | 17.7 | 94,927 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Sale of securities on an exchange or to another person at price $ 18.22 per share. | 04 Apr 2024 | 3,165 | 0 (0%) | 0% | 18.2 | 57,666 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Sale of securities on an exchange or to another person at price $ 16.38 per share. | 04 Apr 2024 | 232 | 8,516 (0%) | 0% | 16.4 | 3,800 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Sale of securities on an exchange or to another person at price $ 15.51 per share. | 04 Apr 2024 | 147 | 8,748 (0%) | 0% | 15.5 | 2,280 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 06 Mar 2024 | 19,625 | 8,895 (0%) | 0% | 21.5 | 421,938 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 10,875 | 0 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.50 per share. | 06 Mar 2024 | 10,875 | 19,770 (0%) | 0% | 11.5 | 125,063 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 8,750 | 39,375 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.15 per share. | 06 Mar 2024 | 8,750 | 28,520 (0%) | 0% | 10.2 | 88,813 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Sale of securities on an exchange or to another person at price $ 17.22 per share. | 26 Feb 2024 | 16,124 | 8,895 (0%) | 0% | 17.2 | 277,655 | Common Stock |
| Macrogenics Inc | Jeffrey Peters Stuart | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 26,250 | 0 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Jeffrey Peters Stuart | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 26,250 | 35,145 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Peters Jeffrey Stuart | Senior VP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.11 per share. | 22 Feb 2024 | 10,126 | 25,019 (0%) | 0% | 17.1 | 173,256 | Common Stock |
| Macrogenics Inc | Peters Stuart Jeffrey | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 13,336 | 13,336 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 13,336 | 26,664 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Peters Stuart Jeffrey | Senior VP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.40 per share. | 15 Feb 2024 | 4,441 | 8,895 (0%) | 0% | 17.4 | 77,273 | Common Stock |
| Macrogenics Inc | Peters Stuart Jeffrey | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 71,000 | 71,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 27,000 | 27,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Peters Jeffrey Stuart | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.50 per share. | 05 Feb 2024 | 54,376 | 54,376 (0%) | 0% | 11.5 | 625,324 | Common Stock |
| Macrogenics Inc | Peters Jeffrey Stuart | Senior VP and General Counsel | Sale of securities on an exchange or to another person at price $ 16.50 per share. | 05 Feb 2024 | 54,376 | 21,875 (0%) | 0% | 16.5 | 897,204 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 54,376 | 10,875 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Stuart Jeffrey Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 21,875 | 48,125 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Stuart Peters Jeffrey | Senior VP and General Counsel | Sale of securities on an exchange or to another person at price $ 16.50 per share. | 05 Feb 2024 | 21,875 | 0 (0%) | 0% | 16.5 | 360,938 | Common Stock |
| Macrogenics Inc | Peters Stuart Jeffrey | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.15 per share. | 05 Feb 2024 | 21,875 | 76,251 (0%) | 0% | 10.1 | 222,031 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Sale of securities on an exchange or to another person at price $ 6.03 per share. | 10 Mar 2023 | 5,372 | 0 (0%) | 0% | 6.0 | 32,393 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 8,750 | 0 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 8,750 | 8,750 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 22 Feb 2023 | 3,378 | 5,372 (0%) | 0% | 6.6 | 22,126 | Common Stock |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 170,000 | 170,000 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 40,000 | 40,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 70,000 | 70,000 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 35,000 | 35,000 | - | - | Restricted Stock Unit |